NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for cyclosporine


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
BARACLUDE(R) entecavir Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
2009 NOV 16 ... received or is receiving an immunosuppressant that may affect renal function, such as cyclosporine or tacrolimus. Since entecavir is primarily eliminated by the kidneys, ...
Subject: Bristol-Myers Squibb
Price: $3.00
*
Data from University of Toronto provide new insights into sleep disorders
2009 NOV 23 ... (28.0 +/- 26.9 vs. 10.4 +/- 6.4 per hour, p = 0.025) compared to the non-SDB group. Cyclosporine use was associated with CSA (p = 0.006). Recipients with OSA had a greater change (pre ...
Subject: Sleep Disorders
Price: $3.00
*
Inspire Reports Third Quarter 2009 Financial Results
2009 NOV 16 ... HCl ophthalmic solution) 0.05% and royalty revenue from net sales of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%, as compared to $15.2 million in the third quarter of 2008. ...
Subject: Inspire Pharmaceuticals, Inc.
Price: $3.00
*
New cardiology research presented at CHEST 2009
2009 NOV 16 ... transplantation. For the 2 years after transplantation, 36 patients were treated with cyclosporine plus mycophenolate, 154 with tacrolimus plus mycophenolate, and 10 with prednisone plus ...
Subject: American College of Chest Physicians
Price: $3.00
*
New findings from School of Dentistry in the area of apoptosis animal studies published
2009 NOV 23 ... Fresh data on apoptosis are presented in the report 'Cyclosporine A enhances apoptosis in gingival keratinocytes of rats and in OECM1 cells via the ...
Subject: Apoptosis Animal Studies
Price: $3.00
*
New psoriasis study findings have been published by R. Bissonnette and colleagues
2009 NOV 23 ... years, the mainstays of psoriasis therapy were conventional oral immunosuppressants (eg, cyclosporine and methotrexate) and retinoids. Recently, six biologic agents were approved for the ...
Subject: Psoriasis
Price: $3.00
*
New stem cell research study results reported from Emory University
2009 NOV 16 ... spinal cord. Twenty-four 30- to 40-kg female Yorkshire farm pigs immunosuppressed with cyclosporine underwent a cervical laminectomy and ventral horn human neural progenitor cell ...
Subject: Stem Cell Research
Price: $3.00
*
Reports outline pseudotumor cerebri study findings from Kosin University
2009 NOV 23 ... Asian woman who developed pseudotumor cerebri (PTC) 2 years after renal transplantation. Cyclosporine A (CsA) was the only medication with a known neurotoxic side effect among her ...
Subject: Pseudotumor Cerebri
Price: $3.00
*
Reports outline pulmonary fibrosis study findings from M.B. Shadmehr and colleagues
2009 NOV 9 ... carried out using standardized methods. The induction suppression regimen consisted of cyclosporine and methylprednisolone. Maintenance immunosuppression drugs were...
Subject: Pulmonary Fibrosis
Price: $3.00
*
Reports summarize stem cell research study results from Shiraz University
2009 NOV 9 ... conditioning regimen, graft-versus-host disease (GVHD) symptoms, use of prednisolone and cyclosporine as prophylaxis treatment of GVHD, and gancyclovir and IVIg as antiviral drugs." ...
Subject: Stem Cell Research
Price: $3.00
*
Research from B. Einollahi and co-researchers in the area of thrombocytopenic purpura published
2009 NOV 9 ... induction therapy with antithymocyte globulin (ATG) and maintenance treatment with cyclosporine and prednisone. Kidney transplantations were safely performed without any complication. ...
Subject: Thrombocytopenic Purpura
Price: $3.00
*
Research from Toho University in membranous nephropathy provides new insights
2009 NOV 16 ... "His renal biopsy showed membranous nephropathy. He was treated with prednisolone and cyclosporine A. Proteinuria disappeared 3 months after the onset of nephrotic syndrome," wrote O. ...
Subject: Membranous Nephropathy
Price: $3.00
*
Research on angiotensins detailed by scientists at University of Dusseldorf
2009 NOV 16 ... transplant function, and frequent rejections. Pattern recognition identified, the use of cyclosporine (odds ratio of 4.25) and the use of Ang II-receptor-blockers at discharge indicating the ...
Subject: Angiotensins
Price: $3.00
*
Research on autoimmune disease reported by M.C. Salinascarmona et al
2009 NOV 23 ... mofetil (MMF) and azathioprine (AZA) decreased more than 60% of B-1a lymphocytes while cyclosporine (CsA) had little effect. Three drugs PDN, AZA and CYC suppressed the B-2 cells on day ...
Subject: Autoimmune Disease
Price: $3.00
*
Research on insulin resistance reported by R. Hekmat et al
2009 NOV 9 ... .018 and .024, respectively). Regression models showed that only cumulative administered cyclosporine dose and plasma creatinine were significantly (or near significantly) associated with IR ...
Subject: Insulin Resistance
Price: $3.00
*
Scientists at Chung-Shan Medical University target phosphatase
2009 NOV 9 ... in the Xenopus oocyte system. Treatment with the ser/thr phosphatase inhibitors, cyclosporine (2 mu mol/L), calyculin A (2 mu mol/L) or okadaic acid (1 mu mol/L), caused a ...
Subject: Phosphatase
Price: $3.00
*
SCYNEXIS' SCY-635 Demonstrates Positive Antiviral Activity in Combination with Approved and Investigational Anti-HCV Agents
2009 NOV 16 ... synthesized within a cell. Scientists at SCYNEXIS have synthesized derivatives of Cyclosporine A in which cyclophilin binding activity (which mediates anti-HCV activity) is separated ...
Subject: SCYNEXIS, Inc.
Price: $3.00
*
Study data from Beaumont Hospital update knowledge of cardiovascular
2009 NOV 16 ... respectively. Cholesterol reduction was significantly greater in the group that received cyclosporine (n = 29) compared with a tacrolimus and mycophenolic acid mofetil (MMF) combination (1.3 ...
Subject: Cardiovascular
Price: $3.00
*
Study results from H.T. Khosroshahi and colleagues broaden understanding of transplantation
2009 NOV 9 ... plasma renin activity in the recipient," researchers in Iran report. "Cyclosporine (CsA) nephrotoxicity is another cause of early kidney allograft dysfunction. To evaluate ...
Subject: Transplantation
Price: $3.00
*
Study results from University of Tehran in the area of monoclonal antibodies published
2009 NOV 9 ... was administered to all participants: oral prednisolone, mycophenolate mofetil, and cyclosporine. Delayed graft function (DGF), acute rejection, prednisolone pulses and/or ...
Subject: Monoclonal Antibodies
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login